Delivery Order SPE2DB22D3501-SPE2DB23FWS64
Award Date 8/3/23
Potential Completion Date 8/24/23
Potential Value $45K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a $67,856 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Ocrevus 300 MG/10 ML vials. Under this order, Amerisourcebergen will deliver 10 ML vials of the multiple sclerosis treatment Ocrevus to a facility in Conshohocken, Pennsylvania. The order is funded by the Defense Logistics Agency and was awarded on September 27, 2023, with performance required by October 19, 2023. No set aside designation or subcontractors were identified....
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $45,237.44 to Amerisourcebergen Drug Corporation for the supply of 4562055207 Ocrevus 300 MG/10 ML Vials. Amerisourcebergen will deliver 10ML vials of the multiple sclerosis treatment Ocrevus to a location in Conshohocken, Pennsylvania under a start date of September 5, 2023 concluding on September 26, 2023. The prime contractor, Amerisourcebergen Drug Corporation, is a division of Amerisourcebergen Corporation. The...
- The Defense Logistics Agency awarded a $113,093.60 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Ocrevus 300 MG/10 ML vials. Under this contract, Amerisourcebergen will deliver 4562277151 units of the multiple sclerosis treatment Ocrevus to locations in Conshohocken, Pennsylvania by October 16, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations and works to support all military services and combatant commands. This...
- The Defense Logistics Agency awarded a $48,077.16 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Ocrevus 300 mg/10 mL vials on September 19, 2025, with an ultimate completion date of October 10, 2025. This non-competitive delivery order was placed against AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999 and extending through December 2026. The product will be delivered to AmerisourceBergen's...
- The Defense Logistics Agency awarded a $67,856 firm fixed price delivery order to Amerisourcebergen Drug Corporation for Ocrevus 300 MG/10 ML vials. Under this order, Amerisourcebergen will deliver 4562126837 units of the multiple sclerosis treatment to a facility in Conshohocken, Pennsylvania by October 2, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations and works to support all military services and combatant commands. This delivery order was...
- The Defense Logistics Agency awarded a $45,237 delivery order to Amerisourcebergen Drug Corporation for Ocrevus 300 MG/10 ML vials. Under this firm fixed price contract, Amerisourcebergen will provide 10 mL vials of the multiple sclerosis treatment Ocrevus to support the Defense Logistics Agency's medical supply needs. Performance will occur at Amerisourcebergen's facility in Conshohocken, Pennsylvania over a three week period concluding in mid-August. No subcontractors or set aside designations...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at one hundred thirteen thousand ninety-three dollars and sixty cents ($113,093.60) to Amerisourcebergen Drug Corporation for Ocrevus 300 MG/10 ML vials. Performance will occur in Conshohocken, Pennsylvania under the prime contractor's corporate office division. The order runs from August 28th through September 19th, 2023 to supply the pharmaceutical product to the Agency. No set aside designation or subcontracting...
- The Defense Logistics Agency awarded a $67,856 delivery order to Amerisourcebergen Drug Corporation for Ocrevus 300 MG/10 ML vials. Under the terms of the firm fixed price contract, Amerisourcebergen will deliver 10 ML vials of the multiple sclerosis treatment Ocrevus to a facility in Conshohocken, Pennsylvania. Performance will take place between July 14 and August 4, 2023. The Defense Logistics Agency manages the Department of Defense's global logistics operations and works to support the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 22, 2025, for the supply of Ocrevus 300 mg/10 mL vials with a ceiling value of $120,192.80 and a firm fixed price structure. The order is scheduled for completion by October 14, 2025, and will be fulfilled from the contractor's facility in Conshohocken, Pennsylvania. This non-competitive delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order valued at $48,077.16 to AmerisourceBergen Drug Corp for the supply of Ocrevus 300 mg/10 ml vials. This non-set-aside, firm fixed price delivery order is scheduled for completion by September 3, 2025, and will be performed at the contractor's Conshohocken, Pennsylvania facility. Ocrevus is a specialty pharmaceutical product used in the treatment of multiple sclerosis, reflecting the critical role AmerisourceBergen plays in supplying...